Bicycle Therapeutics of the UK has raised £20 million in equity financing to bring its candidate peptide therapeutics into clinical development in cancer indications. The technology combines features of both antibodies and small-molecule drugs. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
